Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.290
+0.070 (1.66%)
At close: Mar 9, 2026, 4:00 PM EDT
4.210
-0.080 (-1.86%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Aquestive Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 121.17 | 71.55 | 23.87 | 27.27 | 28.02 | Upgrade
|
| Cash & Short-Term Investments | 121.17 | 71.55 | 23.87 | 27.27 | 28.02 | Upgrade
|
| Cash Growth | 69.36% | 199.71% | -12.47% | -2.68% | -11.89% | Upgrade
|
| Accounts Receivable | 17.76 | 7.34 | 8.47 | 4.7 | 12.12 | Upgrade
|
| Receivables | 17.76 | 7.34 | 8.47 | 4.7 | 12.12 | Upgrade
|
| Inventory | 6.17 | 6.04 | 6.77 | 5.78 | 4.04 | Upgrade
|
| Prepaid Expenses | 4.17 | 3.29 | 1.85 | 2.13 | 3.08 | Upgrade
|
| Total Current Assets | 149.27 | 88.22 | 40.97 | 39.89 | 47.26 | Upgrade
|
| Property, Plant & Equipment | 8.51 | 8.98 | 9.74 | 9.3 | 7.78 | Upgrade
|
| Other Intangible Assets | - | - | 1.28 | 1.44 | 0.05 | Upgrade
|
| Other Long-Term Assets | 2.64 | 4.22 | 5.44 | 6.45 | 6.9 | Upgrade
|
| Total Assets | 160.43 | 101.42 | 57.42 | 57.07 | 61.99 | Upgrade
|
| Accounts Payable | 29.86 | 10.29 | 8.93 | 9.95 | 8.31 | Upgrade
|
| Accrued Expenses | 5.03 | 5.99 | 6.5 | 7.97 | 8.74 | Upgrade
|
| Current Portion of Long-Term Debt | 9.99 | 0.03 | 0.02 | 18.7 | 2.03 | Upgrade
|
| Current Portion of Leases | 0.63 | 0.51 | 0.39 | 0.26 | 0.9 | Upgrade
|
| Current Unearned Revenue | 2.09 | 2.05 | 2.47 | 2.66 | 1.99 | Upgrade
|
| Total Current Liabilities | 47.61 | 18.87 | 18.31 | 39.53 | 21.96 | Upgrade
|
| Long-Term Debt | 27.41 | 32.35 | 27.34 | 33.45 | 51.55 | Upgrade
|
| Long-Term Leases | 4.45 | 5.11 | 5.57 | 5.09 | 1.95 | Upgrade
|
| Long-Term Unearned Revenue | 81.41 | 82.72 | 95.91 | 95.53 | 66.18 | Upgrade
|
| Other Long-Term Liabilities | 33.21 | 22.52 | 16.78 | 2.03 | 2.49 | Upgrade
|
| Total Liabilities | 194.09 | 161.58 | 163.91 | 175.62 | 144.13 | Upgrade
|
| Common Stock | 0.12 | 0.09 | 0.07 | 0.06 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 413.21 | 302.97 | 212.52 | 192.6 | 174.62 | Upgrade
|
| Retained Earnings | -447 | -363.21 | -319.08 | -311.21 | -256.8 | Upgrade
|
| Total Common Equity | -33.66 | -60.16 | -106.49 | -118.55 | -82.13 | Upgrade
|
| Shareholders' Equity | -33.66 | -60.16 | -106.49 | -118.55 | -82.13 | Upgrade
|
| Total Liabilities & Equity | 160.43 | 101.42 | 57.42 | 57.07 | 61.99 | Upgrade
|
| Total Debt | 42.48 | 38 | 33.32 | 57.49 | 56.42 | Upgrade
|
| Net Cash (Debt) | 78.69 | 33.54 | -9.45 | -30.22 | -28.4 | Upgrade
|
| Net Cash Growth | 134.59% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.74 | 0.39 | -0.15 | -0.62 | -0.75 | Upgrade
|
| Filing Date Shares Outstanding | 122.05 | 98.87 | 73.3 | 55.87 | 41.47 | Upgrade
|
| Total Common Shares Outstanding | 122.04 | 91.41 | 68.53 | 54.83 | 41.23 | Upgrade
|
| Working Capital | 101.66 | 69.36 | 22.66 | 0.36 | 25.3 | Upgrade
|
| Book Value Per Share | -0.28 | -0.66 | -1.55 | -2.16 | -1.99 | Upgrade
|
| Tangible Book Value | -33.66 | -60.16 | -107.77 | -119.99 | -82.19 | Upgrade
|
| Tangible Book Value Per Share | -0.28 | -0.66 | -1.57 | -2.19 | -1.99 | Upgrade
|
| Machinery | 24.29 | 23.77 | 23.64 | 23.21 | 22.49 | Upgrade
|
| Construction In Progress | 2.2 | 2.11 | 2.03 | 1.47 | 1.16 | Upgrade
|
| Leasehold Improvements | 21.42 | 21.42 | 21.39 | 21.38 | 21.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.